NCT07752511Not yet recruiting
Anticipated Stigma, Illness Identity, and Quality of Life in Male Hypogonadism
The Impact of Anticipated Illness Stigma and Illness Identity on Quality of Life in Men With Hypogonadism: A Comparative Study With Other Chronic Endocrine Diseases
Source: ClinicalTrials.gov · Last updated 7 Aug 2026
Brief summary (registry, in English)
This study aims to systematically compare the levels of anticipated illness stigma and illness identity among men diagnosed with hypogonadism to those of men with other chronic endocrine conditions (e.g., diabetes mellitus, hypothyroidism, and hypertension). Furthermore, it examines whether these psychosocial variables predict quality-of-life deterioration specifically within the hypogonadism cohort.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 90 (estimated)
- First submitted
- 4 Aug 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 20 Oct 2027
- Lead sponsor
- Hacettepe University
- Diseases
- High blood pressure
- NCT number
- NCT07752511
What you commit to
- Study type: Observational
- Planned participants: 90
- From 1 Oct 2026 to the primary completion date, 20 Oct 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Active psychiatric diagnosis (e.g., active psychosis, bipolar disorder).
- Chronic inflammatory or rheumatological diseases affecting body composition (e.g., chronic kidney disease, IBD, rheumatoid arthritis, SLE, ankylosing spondylitis).
- Cognitive impairment or dementia precluding questionnaire completion.
- Klinefelter syndrome.
Lab values
- Uncontrolled co-existing endocrine conditions or severe complications (e.g., HbA1c \> 8.0%, diabetic neuropathy/nephropathy/retinopathy, non-euthyroid state).
Other
- Literacy limitations preventing completion of self-report measures.
- Additional control exclusion: Diagnosis or clinical suspicion of hypogonadism.
Who the study is looking for
- Cases:
- Male, aged 18 years or older.
- Biochemically confirmed hypogonadism (total testosterone \< 300 ng/dL with at least one clinical symptom).
- Regular follow-up at the endocrinology outpatient clinic.
- Fluent in reading and understanding Turkish.
- Signed informed consent.
- Controls:
- Male, aged 18 years or older.
- Diagnosed with diabetes, hypertension, or hypothyroidism under regular endocrinology follow-up.
- Total testosterone ≥ 300 ng/dL.
- Age-matched to a participant in the case group (±5 years).
- Fluent in reading and understanding Turkish.
- Signed informed consent.
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bingöl University Faculty of Physical Therapy and Rehabilitation Coordinator of this site? Confirm its status | Bingoel | Turkey (Türkiye) | Unknown status |
| Malatya Training and Research Hospital Coordinator of this site? Confirm its status | Malatya | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.